| Old Articles: <Older 5751-5760 Newer> |
 |
The Motley Fool February 10, 2005 Tim Beyers |
Apple Won't Get Sirius Sirius CEO Mel Karmazin chats with Steve Jobs and gets nowhere. Why not? Investors have a right to turn a furrowed brow toward Jobs on this move.  |
The Motley Fool February 10, 2005 Rich Smith |
Short Circuit From Daktronics The electronics company warns on third-quarter earnings.  |
The Motley Fool February 10, 2005 Stephen D. Simpson |
Winn-Dixie Not Ready to Check Out Southern supermarket keeps trying to turn around, but the stock still looks more like a value trap than a value play.  |
The Motley Fool February 10, 2005 Salim Haji |
Stellar Quarter for Whole Foods The company turned in another great quarter, highlighting the fundamental strength of the company's core business model. Unfortunately for investors, at the current stock price, the stock is fully valued or close to it.  |
The Motley Fool February 10, 2005 Stephen D. Simpson |
MetLife Lives the Good Life This huge insurer is taking surprisingly active steps to produce ongoing growth for shareholders.  |
The Motley Fool February 10, 2005 Bill Mann |
Level 3 Down to Level 2 The low-cost telecommunications backbone provider in the U.S.cries uncle after putting pressure on competitors with its low cost structure.  |
The Motley Fool February 10, 2005 Dave Marino-Nachison |
High Five for Big 5 The sporting goods retailer may be leaving sales on the table, but its brick-and-mortar formula is working. Since its 2002 IPO, it has beaten the S&P 500 by a healthy margin.  |
The Motley Fool February 10, 2005 David Meier |
Dressing for Success With VF A great year propels the apparel company's stock to new highs.  |
The Motley Fool February 10, 2005 Steven Mallas |
Atari's Quarterly Woes Atari struggles in its fiscal third quarter. The stock closed yesterday at $2.72; it's at such a level for a reason.  |
The Motley Fool February 10, 2005 Karl Thiel |
The Worst Has Happened. Time to Sell? Biotech stocks can be volatile, but dumping them in response to bad news isn't always the smartest option: Axonyx... Icos Pharmaceuticals... etc.  |
| <Older 5751-5760 Newer> Return to current articles. |